Marr RA - Search Results

1

Neprilysin regulates amyloid Beta peptide levels.

Marr RA, Guan H, Rockenstein E, Kindy M, Gage FH, Verma I, Masliah E, Hersh LB. Marr RA, et al. J Mol Neurosci. 2004;22(1-2):5-11. doi: 10.1385/JMN:22:1-2:5. J Mol Neurosci. 2004. PMID: 14742905

2

Neprilysin gene transfer reduces human amyloid pathology in transgenic mice.

Marr RA, Rockenstein E, Mukherjee A, Kindy MS, Hersh LB, Gage FH, Verma IM, Masliah E. Marr RA, et al. J Neurosci. 2003 Mar 15;23(6):1992-6. doi: 10.1523/JNEUROSCI.23-06-01992.2003. J Neurosci. 2003. PMID: 12657655 Free PMC article.

3

Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model.

Singer O, Marr RA, Rockenstein E, Crews L, Coufal NG, Gage FH, Verma IM, Masliah E. Singer O, et al. Among authors: marr ra. Nat Neurosci. 2005 Oct;8(10):1343-9. doi: 10.1038/nn1531. Epub 2005 Aug 28. Nat Neurosci. 2005. PMID: 16136043

4

Long-term neprilysin gene transfer is associated with reduced levels of intracellular Abeta and behavioral improvement in APP transgenic mice.

Spencer B, Marr RA, Rockenstein E, Crews L, Adame A, Potkar R, Patrick C, Gage FH, Verma IM, Masliah E. Spencer B, et al. Among authors: marr ra. BMC Neurosci. 2008 Nov 12;9:109. doi: 10.1186/1471-2202-9-109. BMC Neurosci. 2008. PMID: 19014502 Free PMC article.

5

Neuropeptide Y fragments derived from neprilysin processing are neuroprotective in a transgenic model of Alzheimer's disease.

Rose JB, Crews L, Rockenstein E, Adame A, Mante M, Hersh LB, Gage FH, Spencer B, Potkar R, Marr RA, Masliah E. Rose JB, et al. Among authors: marr ra. J Neurosci. 2009 Jan 28;29(4):1115-25. doi: 10.1523/JNEUROSCI.4220-08.2009. J Neurosci. 2009. PMID: 19176820 Free PMC article.

6

Neprilysin: an enzyme candidate to slow the progression of Alzheimer's disease.

El-Amouri SS, Zhu H, Yu J, Marr R, Verma IM, Kindy MS. El-Amouri SS, et al. Am J Pathol. 2008 May;172(5):1342-54. doi: 10.2353/ajpath.2008.070620. Epub 2008 Apr 10. Am J Pathol. 2008. PMID: 18403590 Free PMC article.

7

An antiaggregation gene therapy strategy for Lewy body disease utilizing beta-synuclein lentivirus in a transgenic model.

Hashimoto M, Rockenstein E, Mante M, Crews L, Bar-On P, Gage FH, Marr R, Masliah E. Hashimoto M, et al. Gene Ther. 2004 Dec;11(23):1713-23. doi: 10.1038/sj.gt.3302349. Gene Ther. 2004. PMID: 15483670

8

Neprilysin-2 is an important β-amyloid degrading enzyme.

Hafez D, Huang JY, Huynh AM, Valtierra S, Rockenstein E, Bruno AM, Lu B, DesGroseillers L, Masliah E, Marr RA. Hafez D, et al. Among authors: marr ra. Am J Pathol. 2011 Jan;178(1):306-12. doi: 10.1016/j.ajpath.2010.11.012. Epub 2010 Dec 23. Am J Pathol. 2011. PMID: 21224067 Free PMC article.

9

Peripheral delivery of a CNS targeted, metalo-protease reduces aβ toxicity in a mouse model of Alzheimer's disease.

Spencer B, Marr RA, Gindi R, Potkar R, Michael S, Adame A, Rockenstein E, Verma IM, Masliah E. Spencer B, et al. Among authors: marr ra. PLoS One. 2011 Jan 31;6(1):e16575. doi: 10.1371/journal.pone.0016575. PLoS One. 2011. PMID: 21304989 Free PMC article.

10

Novel strategies for Alzheimer's disease treatment.

Spencer B, Rockenstein E, Crews L, Marr R, Masliah E. Spencer B, et al. Expert Opin Biol Ther. 2007 Dec;7(12):1853-67. doi: 10.1517/14712598.7.12.1853. Expert Opin Biol Ther. 2007. PMID: 18034651 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters